Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Does Radiofrequency Ablation of the Articular Nerves of the Knee Prior to Total Knee Replacement Improve Pain Outcomes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02746874
Recruitment Status : Completed
First Posted : April 21, 2016
Results First Posted : February 2, 2021
Last Update Posted : February 2, 2021
Sponsor:
Information provided by (Responsible Party):
David Walega, Northwestern University

Brief Summary:

More than 300,000 total knee joint replacement surgeries are performed per year in the United States and safe, effective management of post-operative pain in these patients, often elderly, deconditioned, obese, or with co-morbid diseases like sleep apnea, can be challenging and often require a multidisciplinary, multimodal approach. Opiates have been a mainstay of treatment in the post-operative period with varying degrees of success and complications. Inadequately controlled postoperative pain is not uncommon. Poorly controlled pain inhibits early mobilization and hinders post-operative physical therapy.

A new paradigm for treating post-operative pain following total knee replacement may be the use of cooled radiofrequency ablation (C-RFA) of the articular sensory nerve supply of the knee capsule prior to surgery, to desensitize the knee by blocking sensory afferents to the anterior capsule and thereby decrease post-operative pain. There are several publications that have demonstrated the use of RFA in patients with chronic knee pain from osteoarthritis however the use of RFA in the preoperative management of pain in patients undergoing total knee joint replacement has not been investigated.

The aim of this study is to determine if patients undergoing unilateral total knee replacement obtain any post-operative pain relieving benefits from C-RFA of the articular sensory nerve supply when performed prior to surgery, as compared to sham controls who receive only local anesthetic injections of these same nerves without the benefit of ablation treatment.


Condition or disease Intervention/treatment Phase
Arthroplasty, Replacement, Knee Procedure: Radiofrequency Ablation (RFA) Procedure: Simulated Radiofrequency Ablation (RFA) Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 70 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Does Radiofrequency Ablation of the Articular Nerves of the Knee Prior to Total Knee Replacement Improve Pain Outcomes? A Prospective Randomized Sham-Control Trial With 6 Month Follow Up
Actual Study Start Date : December 1, 2016
Actual Primary Completion Date : June 30, 2017
Actual Study Completion Date : December 31, 2017

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Knee Replacement

Arm Intervention/treatment
Active Comparator: Active Group
Radiofrequency ablation procedure of the three articular branches of the knee joint. The targets will be thermally lesioned for 2 minutes 30 seconds thereby causing neurolysis.
Procedure: Radiofrequency Ablation (RFA)
The radiofrequency generator which will be turned on but will not be in the patient's view. The skin overlying the target sites identified with image guidance will be numb using lidocaine 1%. A needle will be placed through the skin to be optimally positioned according to the three targets. Sensory and motor testing will be performed to confirm appropriate placement. Lidocaine 2% 1-2cc will be injected prior to lesioning.

Sham Comparator: Placebo Group
Simulated Radiofrequency Ablation procedure of the three articular branches of the knee joint.The targets will be not be thermally lesioned for 2 minutes 30 seconds therefore not causing neurolysis.
Procedure: Simulated Radiofrequency Ablation (RFA)
The radiofrequency generator which will be turned on but will not be in the patient's view. The skin overlying the target sites identified with image guidance will be numb using lidocaine 1%. A needle will be placed through the skin to be optimally positioned according to the three targets. Sensory and motor testing will be performed to confirm appropriate placement. Lidocaine 2% 1-2cc will be injected. A simulate sham lesion will be performed at each target site.




Primary Outcome Measures :
  1. Opioid Consumption After Surgery [ Time Frame: 48 hours ]
    Pain medication will be calculated into oral morphine equivalents (ME) for the first 48 hours after surgery. Morphine equivalents determine a patient's cumulative intake of any drugs in the opioid class.


Secondary Outcome Measures :
  1. Oral Morphine Equivalent Milligrams at Baseline. [ Time Frame: Pre operative ]
    The total morphine equivalent (milligrams) reported by the subject at baseline.

  2. Oral Morphine Equivalents at Baseline Compared to 48 Hours Post-operative. [ Time Frame: 48 hours ]
    Total oral morphine equivalents at baseline compared to oral morphine equivalents at 48 hours post-operative.

  3. Medication Quantification Scale III (MQSIII) Score 48 Hours Post-operative. [ Time Frame: 48 hours ]
    Medication Quantification Scale III (MQSIII) is a method of quantifying different pain drug regimens by evaluating the use of 22 distinct drug classes (e.g., nonsteroidal anti-inflammatory drugs [NSAIDs], antidepressants, benzodiazepines, opiates). A single value is calculated based on a patient's pain medication profile, taking into account dosages, and the types of pain medications prescribed. The score is calculated for a given pharmacologic class by taking its detriment weight, as determined by the physician, multiplied by a score given for dosage. The scores for each pharmacologic class prescribed to a patient are then summed to determine the overall score of a given pain medication regimen. The scale ranges from (0 low (good) 500 high (poor).

  4. Number of Stairs Climbed on Post-operative Day 2. [ Time Frame: Post operative day 2 ]
    Number of stairs climbed on post-operative day 2 prior to discharge from the hospital.

  5. Distance Walked on Post-operative Day 2. [ Time Frame: Post operative day 2 ]
    Distance in feet walked on post-operative day 2 prior to discharge from the hospital.

  6. Western Ontario and McMaster Universities Arthritis Index (WOMAC) Score 6 Months Post Operative [ Time Frame: 6 months post operative ]
    Western Ontario and McMaster Universities Arthritis Index (WOMAC) score 6 months post operative. The WOMAC score is a survey comprised of 24 items divided into three subscales: Pain (5 items), stiffness (2 items), and physical function (17 items). Subjects are asked a range of questions about their ability to carry out daily activities such as using the stairs, rising from sitting, lying in bed and conducting light or heavy domestic duties. Items are scored on a scale of 0-4 (lower scores indicate lower levels of symptoms or physical disability). Values are summed up for a combined WOMAC score of 0 (low) to 96 (high) Higher scores on the WOMAC indicate worse pain, stiffness, and functional limitation.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   30 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • osteoarthritis of the knee scheduled to undergo their first unilateral knee joint replacement
  • willingness to undergo fluoroscopy-guided C-RFA or sham treatment

Exclusion Criteria:

  • pregnancy,
  • severe cardiac/pulmonary compromise,
  • acute illness/infection,
  • coagulopathy
  • bleeding disorder,
  • allergic reactions,
  • contraindications to a local anesthetic

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02746874


Locations
Layout table for location information
United States, Illinois
Anesthesiology Pain Medicine Center
Chicago, Illinois, United States, 60611
Sponsors and Collaborators
Northwestern University
Investigators
Layout table for investigator information
Principal Investigator: David Walega, MD Northwestern University Feinberg School of Medicine
  Study Documents (Full-Text)

Documents provided by David Walega, Northwestern University:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: David Walega, Associate Professor of Anesthesiology, Northwestern University
ClinicalTrials.gov Identifier: NCT02746874    
Other Study ID Numbers: STU00200439
First Posted: April 21, 2016    Key Record Dates
Results First Posted: February 2, 2021
Last Update Posted: February 2, 2021
Last Verified: January 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Keywords provided by David Walega, Northwestern University:
Total Knee Replacement, Replacement of the knee joint,